Scientist Fabricates Cancer Data

A postdoc at Harvard Medical School and Brigham and Women’s Hospital is found guilty of falsifying his findings in a lung cancer study.

Written byMegan Scudellari
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

FLICKR, MICHAEL PERECKAS

A former research fellow at the Brigham and Women’s Hospital and Harvard Medical School committed research misconduct, according to the Office of Research Integrity (ORI), which announced its findings in yesterday’s Federal Register.

Based on evidence collected from a joint investigation by Brigham and Harvard, the ORI concluded that Jian Ma “knowingly and intentionally fabricated and falsified data.” Ma falsified immunoblots in an unpublished manuscript investigating a gene’s involvement in lung cancer sensitivity to a drug called rapamycin. The paper containing the falsified data was submitted to the Journal of Clinical Investigation in August 2008, but it was subsequently withdrawn by one of the authors in January 2009 prior to publication. The research was funded by the National Cancer Institute and the National Institutes of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies